Mohamed Farouk Hamissa (Mohamed Nabil Aboul-Enein)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Tissue Engineering

Molecular Docking

Top Venues

Drug development research

Archiv der Pharmazie

Ústav organické chemie a biochemie Akademie věd České republiky

Vysoká skola chemicko-technologická v Praze (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ústav organické chemie a biochemie Akademie věd České republiky Apr 03 2017

Czechia

PhD student :: Spektroskopie a fyzikální organická chemie

National Research Centre

Egypt

Assistant Researcher :: Medicinal and Pharmaceutical Chemsitry Department

Education History

Vysoká skola chemicko-technologická v Praze Apr 03 2017

Czechia

PHD

Cairo University Faculty of Pharmacy

Egypt

MSC :: Pharmaceutical Chemistry Department

German University in Cairo

Egypt

BSC :: Faculty of Pharmacy and Biotechnology

Publications

Taghreed A Majrashi, Ahmed Sabt, Hayam A Abd El Salam, Ghada H Al-Ansary, Mohamed Farouk Hamissa, Wagdy M Eldehna
An updated review of fatty acid residue-tethered heterocyclic compounds: synthetic strategies and biological significance. RSC advances 13 (20) (2023)
Taghreed A Majrashi, Ahmed Sabt, Hayam A Abd El Salam, Ghada H Al-Ansary, Mohamed Farouk Hamissa, Wagdy M Eldehna
An updated review of fatty acid residue-tethered heterocyclic compounds: synthetic strategies and biological significance. RSC advances 13 (20) (2023)
Aida M Abd El-Sattar El-Azzouny, Mohamed Nabil Aboul-Enein, Mohamed Farouk Hamissa
Structural and biological survey of 7-chloro-4-(piperazin-1-yl)quinoline and its derivatives. Drug development research 81 (7) (2020)
Mohamed Farouk Hamissa, Aida M Abd El-Sattar El-Azzouny, Fatma Abdel-Fattah Ragab, Mohamed Farouk Hamissa
Design, Synthesis, and Cytotoxic Evaluation of Certain 7-Chloro-4-(piperazin-1-yl)quinoline Derivatives as VEGFR-II Inhibitors. Archiv der Pharmazie 350 (3-4) (2017)